25 April 2025
Antibiotics Exceptional Reviewers List 2025
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are thrilled to share the Antibiotics Exceptional Reviewers List for 2025. This program is designed to recognize and honor scholars who have consistently delivered exceptional review reports to our journal. Committed to fostering rigorous research and promoting knowledge exchange, Antibiotics recognizes the significant role our reviewers play in maintaining the quality and integrity of the articles we publish. According to recent surveys conducted in 2023, 91% of our authors rated the peer review process as good or excellent, thanks to our pool of excellent reviewers.
We would like to express our sincere appreciation to all the reviewers who have generously volunteered their time and expertise to assist in Antibiotics’ peer-review process. Their dedication and attention to detail in evaluating manuscripts, offering valuable feedback, and contributing to academic rigor are truly commendable.
The Exceptional Reviewers List was introduced in April 2025. Each quarter, we will select a group of outstanding reviewers and introduce them as follows:
Q1
Q2
Name: Dr. Gesche Först
Affiliation: University of Freiburg, Germany
Name: Dr. Robert Kuthan
Affiliation: Medical University of Warsaw, Poland.
“I view manuscript reviewing as an essential part of academic life. It allows me to promote rigorous science, offer constructive feedback to authors, and stay informed about advances in my field. Engaging in peer review is both a professional duty and a privilege that helps uphold the quality and credibility of medical research.”
Name: Dr. Alexandre Baudet
Affiliation: University of Lorraine, France
“Reviewing manuscripts stimulates critical thinking, enriches reviewers' knowledge and enables us to actively contribute to the progress of scientific research.”
Name: Dr. Teresa Semedo
Affiliation: University of Lisbon, Lisbon, Portugal
“Reviewing scientific manuscripts is my contribution to foster quality science on antimicrobial resistance and One Health, supporting global efforts to protect health across humans, animals, and the environment.”
Name: Dr. Jossue Ortiz-Álvarez
Affiliation: Secretaria de Ciencia, Humanidades, Tecnología e Innovación (SECIHTI), Mexico
“It is very crucial for me to be a reviewer because my participation contributes to the strengthening of the scientific publication with review accuracy.”